Assertio Inc.
0.83
0.03 (4.18%)
At close: Jan 14, 2025, 3:59 PM

Assertio Inc. Revenue Breakdown

Quarter Sep 30, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018
CAMBIA Revenue 1.36M 1.99M 723.00K 697.00K 34.27M 5.81M 35.43M 992.00K 18.34M 26.00M 6.13M 6.46M 12.48M 7.45M 5.43M 9.25M 28.92M 27.50M 25.94M 26.45M 29.34M 29.43M 26.84M 44.35M
CAMBIA Revenue Growth -31.61% +175.66% +3.73% -97.97% +490.07% -83.61% +3471.57% -94.59% -29.44% +324.23% -5.17% -48.21% +67.50% +37.08% -41.27% -68.00% +5.15% +6.03% -1.94% -9.85% -0.33% +9.68% -39.49% n/a
INDOCIN Products Revenue 5.67M 17.95M 1.80M 2.26M 49.86M 21.87M 451.00K 5.47M 32.15M 416.00K 13.07M 14.60M 29.82M 13.77M 20.16M 407.00K 858.00K 341.00K 263.00K 623.00K n/a 20.28M 5.26M n/a
INDOCIN Products Revenue Growth -68.41% +894.35% -20.27% -95.46% +128.01% +4749.00% -91.76% -82.98% +7628.12% -96.82% -10.43% -51.04% +116.47% -31.70% +4854.55% -52.56% +151.61% +29.66% -57.78% n/a n/a +285.71% n/a n/a
Otrexup Revenue 1.80M 35.14M 28.07M 30.35M 786.00K 34.28M n/a 21.36M 1.31M n/a 24.83M 26.41M 361.00K 34.27M 452.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Otrexup Revenue Growth -94.88% +25.15% -7.48% +3760.81% -97.71% n/a n/a +1525.34% n/a n/a -5.96% +7214.40% -98.95% +7480.97% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product Revenue 28.70M 12.00K 40.08M 41.77M 487.00K 884.00K n/a 35.55M 1.19M n/a 542.00K 434.00K 3.83M 299.00K 1.60M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product Revenue Growth +239108.33% -99.97% -4.04% +8476.80% -44.91% n/a n/a +2892.09% n/a n/a +24.88% -88.68% +1181.94% -81.34% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product, Other Revenue 214.00K 490.00K 605.00K 796.00K 2.67M 473.00K n/a 1.64M 1.76M n/a 2.94M 1.70M n/a 5.64M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Product, Other Revenue Growth -56.33% -19.01% -23.99% -70.22% +465.12% n/a n/a -6.86% n/a n/a +73.36% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalties And Milestones Revenue 499.00K 2.54M 2.37M 1.89M n/a 2.46M n/a 1.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalties And Milestones Revenue Growth -80.39% +7.25% +25.62% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
SPRIX Nasal Spray Revenue 2.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
SPRIX Nasal Spray Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020
Canada Revenue 1.90M 2.50M 1.50M
Canada Revenue Growth -24.00% +66.67% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 16.73M 18.39M 18.42M 23.46M 21.00M 16.77M 16.90M 13.71M 11.90M 10.54M 10.64M 13.28M 9.31M 26.23M 7.73M 21.27M 25.75M 28.13M 27.31M 22.95M 36.12M 24.75M 25.05M 25.47M 33.41M 31.31M 29.03M 48.32M 48.85M 50.01M 48.52M 48.46M 51.57M 51.90M 52.56M 58.34M 49.06M 57.41M 34.54M
Selling, General, and Administrative Revenue Growth -9.02% -0.21% -21.48% +11.71% +25.25% -0.79% +23.33% +15.18% +12.87% -0.89% -19.88% +42.56% -64.50% +239.39% -63.66% -17.38% -8.48% +2.99% +19.02% -36.46% +45.90% -1.16% -1.66% -23.77% +6.71% +7.84% -39.91% -1.09% -2.32% +3.07% +0.12% -6.03% -0.63% -1.25% -9.90% +18.90% -14.53% +66.20% n/a
Research and Development Revenue 1.00M 798.00K 733.00K 1.02M 1.32M 503.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a 230.00K 1.32M 1.63M 1.04M 5.58M 1.48M 1.26M 1.79M 2.21M 2.13M 2.18M 1.53M 26.16M 1.76M 5.61M 5.08M 9.15M 10.41M 7.12M 5.95M 61.24M 4.63M 4.71M 1.86M
Research and Development Revenue Growth +25.94% +8.87% -28.42% -22.19% +161.63% n/a n/a n/a n/a n/a n/a n/a n/a n/a -100.00% -82.52% -19.07% +56.20% -81.33% +277.71% +16.86% -29.56% -18.76% +3.76% -2.43% +42.67% -94.16% +1385.46% -68.63% +10.42% -44.46% -12.08% +46.32% +19.62% -90.29% +1222.96% -1.80% +153.71% n/a

Create Price Alert on ASRT

Your price alert will notify you when the stock price is above 0.83.

Add to Watchlist